HIV感染者死因的时间趋势:来自瑞士HIV队列研究的见解
该研究分析了2005至2022年瑞士HIV队列研究中1630例死亡,按HIV死亡编码方案分类死因。HIV/AIDS相关死亡和肝脏相关死亡比例下降,非AIDS非肝癌死亡上升,心血管死亡相对稳定;死亡中位年龄从45.0岁升至61.0岁。
要点
- 2005-2022年瑞士HIV队列共报告1630例死亡,HIV/AIDS相关死亡占9.0%。
- 非AIDS非肝癌死亡占22.9%,肝脏相关死亡占10.2%,心血管相关死亡占9.7%。
- 死亡中位年龄从2005-2007年的45.0岁升至2020-2022年的61.0岁。
核心结论
- HIV/AIDS相关和肝脏相关死亡比例下降,体现抗逆转录病毒治疗(ART)、全面HIV诊疗及针对丙型肝炎病毒合并感染干预措施的有效性。
- 作者认为未来研究应关注癌症和心血管相关疾病,因其已成为HIV感染者新的主要死因。
- 需要综合医疗策略聚焦非AIDS相关合并症、癌症管理并维持肝脏和心血管健康,以缩小HIV感染者与普通人群之间的健康差距。
研究设计与样本
- 研究调查了2005年至2022年间瑞士HIV队列研究中所有报告的死亡病例。
- 死因采用HIV死亡编码方案(Coding Causes of Death in HIV protocol)进行分类。
- 统计分析包括人口学分层以识别时间趋势,以及逻辑回归模型以确定根本死因的相关因素。
主要发现
- 共报告1630例死亡,其中出生时指定为女性的个体占23.7%。
- 死亡包括147例(9.0%)HIV/AIDS相关死亡、373例(22.9%)非AIDS非肝癌死亡、166例(10.2%)肝脏相关死亡和158例(9.7%)心血管相关死亡。
- 死亡中位年龄(四分位距)从2005-2007年的45.0(40.0-53.0)岁增至2020-2022年的61.0(56.0-69.5)岁。
- HIV/AIDS相关和肝脏相关死亡减少,非AIDS非肝癌死亡增加,心血管相关死亡保持相对稳定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advancements in access to antiretroviral therapy (ART) and human immunodeficiency virus (HIV) care have led to a decline in AIDS-related deaths among people with HIV (PWH) in Switzerland. However, data on the ongoing changes in causes of death among PWH over the past 15 years are scarce. METHODS: We investigated all reported deaths in the Swiss HIV Cohort Study between 2005 and 2022. Causes of death were categorized using the Coding Causes of Death in HIV protocol. The statistical analysis included demographic stratification to identify time trends and logistic regression models to determine associated factors for the underlying cause of death. RESULTS: In total, 1630 deaths were reported, with 23.7% of individuals assigned female sex at birth. These deaths included 147 (9.0%) HIV/AIDS-related deaths, 373 (22.9%) due to non-AIDS, non-hepatic cancers, 166 (10.2%) liver-related deaths, and 158 (9.7%) cardiovascular-related deaths. The median age at death (interquartile range) increased from 45.0 (40.0-53.0) years in 2005-2007 to 61.0 (56.0-69.5) years in 2020-2022. HIV/AIDS- and liver-related deaths decreased, whereas deaths from non-AIDS, non-hepatic cancers increased and cardiovascular-related deaths remained relatively stable. CONCLUSIONS: The proportionally decreasing HIV/AIDS and liver-related deaths showcase the effectiveness of ART, comprehensive HIV patient care, and interventions targeting hepatitis C virus coinfection. Future research should focus on managing cancer and cardiovascular-related conditions as the new leading causes of death among PWH. Comprehensive healthcare strategies focusing on non-AIDS-related comorbid conditions, cancer management, and sustaining liver and cardiovascular health are needed to bridge the ongoing health disparities between PWH and the general population.
引用
- Weber MSR, Duran Ramirez JJ, Hentzien M, et al. Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study. Clin Infect Dis. 2024. PMID: 38214897. doi:10.1093/cid/ciae014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。